Atheronova Inc (AHROQ) financial statements (2020 and earlier)

Company profile

Business Address 2301 DUPONT DRIVE, SUITE 525
IRVINE, CA 92612
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2014
TTM
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 2662,744
Cash and cash equivalents 2662,744
Prepaid expense and other current assets18
Other current assets 22
Total current assets: 2892,762
Noncurrent Assets
Property, plant and equipment 79
Deposits noncurrent assets 1324
Total noncurrent assets: 2032
TOTAL ASSETS: 3092,794
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 811604
Other undisclosed accounts payable and accrued liabilities 811604
Debt 390 
Other undisclosed current liabilities 7637
Total current liabilities: 1,278641
Noncurrent Liabilities
Long-term debt and lease obligation 363361
Long-term debt, excluding current maturities 363361
Other undisclosed noncurrent liabilities 1,171 
Total noncurrent liabilities: 1,534361
Total liabilities: 2,8121,001
Stockholders' equity
Stockholders' equity attributable to parent, including: (2,503)1,793
Common stock 44
Additional paid in capital 19,52316,004
Accumulated deficit (2,503)(14,215)
Other undisclosed stockholders' equity attributable to parent (19,527) 
Total stockholders' equity: (2,503)1,793
TOTAL LIABILITIES AND EQUITY: 3092,794

Income statement (P&L) ($ in thousands)

9/30/2014
TTM
12/31/2013
12/31/2012
Operating expenses (4,845)(3,638)
Operating loss: (4,845)(3,638)
Nonoperating income (expense) (599)5,143
Investment income, nonoperating  2,640
Debt instrument, convertible, beneficial conversion feature  1,498
Other nonoperating income 21,004
Interest and debt expense (602)(871)
Other undisclosed loss from continuing operations before equity method investments, income taxes (1,767)(3,267)
Loss from continuing operations before income taxes: (7,813)(2,634)
Income tax expense (1)(1)
Net loss available to common stockholders, diluted: (7,815)(2,636)

Comprehensive Income ($ in thousands)

9/30/2014
TTM
12/31/2013
12/31/2012
Net loss: (7,815)(2,636)
Comprehensive loss, net of tax, attributable to parent: (7,815)(2,636)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: